We are live on ! Find out more
VIGL

Vigil Neuroscience

Delisted

VIGL was delisted on the 4th of August, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$15.1M
NV
2
Northpond Ventures
Maryland
$10.9M
Citadel Advisors
3
Citadel Advisors
Florida
$5.47M +$9.47K +2,397 +0.1%
AG
4
Artal Group
Luxembourg
$2.89M
CAM
5
Cormorant Asset Management
Massachusetts
$1.59M
PBPIA
6
Pivotal bioVenture Partners Investment Advisor
California
$1.45M
RSCM
7
Rock Springs Capital Management
Maryland
$1.22M
O
8
OrbiMed
New York
$1.06M
Vanguard Group
9
Vanguard Group
Pennsylvania
$914K -$122K -30,990 -8%
DTC
10
Deep Track Capital
Connecticut
$796K -$319K -80,748 -21%
HMC
11
Harvard Management Company
Massachusetts
$747K
LGM
12
Logos Global Management
California
$530K
LCM
13
Laurion Capital Management
New York
$336K +$514K +130,200 New
BlackRock
14
BlackRock
New York
$269K -$788K -199,466 -66%
Barclays
15
Barclays
United Kingdom
$262K -$4.31K -1,092 -1%
DCM
16
DAFNA Capital Management
California
$257K
Goldman Sachs
17
Goldman Sachs
New York
$189K -$3.01K -762 -1%
Citigroup
18
Citigroup
New York
$168K +$3.83K +969 +2%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$153K -$148K -37,435 -39%
PI
20
PEAK6 Investments
Illinois
$135K +$56.6K +14,337 New
Renaissance Technologies
21
Renaissance Technologies
New York
$97K +$68.9K +17,447 +87%
LP
22
LMR Partners
United Kingdom
$65K -$9.1K -2,305 -8%
Adage Capital Partners
23
Adage Capital Partners
Massachusetts
$57K +$88K +22,269 New
State Street
24
State Street
Massachusetts
$47K -$143K -36,105 -66%
Northern Trust
25
Northern Trust
Illinois
$31K -$176K -44,601 -79%